Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 5, 2005 - Issue 1
Submit an article Journal homepage
259
Views
47
CrossRef citations to date
0
Altmetric
Drug Profile

Alemtuzumab

Farhad Ravandi University of Texas, MD Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd., Box 428, Houston, TX 77030-4095, USA. [email protected]
&
Susan O’Brien University of Texas, MD Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd., Box 428, Houston, TX 77030-4095, USA. [email protected]
Pages 39-51 | Published online: 10 Jan 2014

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Seok Jin Kim, Joon Ho Moon, Hawk Kim, Jin Seok Kim, Yu Yan Hwang, Tanin Intragumtornchai, Surapol Issaragrisil, Jae Yong Kwak, Je Jung Lee, Jong Ho Won, Arry Harryanto Reksodiputro, Soon Thye Lim, Ann-Lii Cheng, Won Seog Kim & Yok Lam Kwong. (2012) Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group. Leukemia & Lymphoma 53:8, pages 1515-1524.
Read now
Lindy G Durrant, Victoria A Pudney & Ian Spendlove. (2011) Using monoclonal antibodies to stimulate antitumor cellular immunity. Expert Review of Vaccines 10:7, pages 1093-1106.
Read now
Carlos Vallejo, Eduardo Ríos, Javier de la Serna, Isidro Jarque, Christelle Ferrá, Pedro Sánchez-Godoy, Carlos Solano, Rafael de la Cámara, Ana Isabel Rosell, Rosario Varela, María Dolores García, Eva González-Barca, Javier López, Elena Pérez, Secundino Ferrer, Luis Felipe Casado, Lourdes Vázquez, Lucía Villalón & José A García-Marco. (2011) Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab. Expert Review of Hematology 4:1, pages 9-16.
Read now
Helen A Papadaki & Charalampos Pontikoglou. (2008) Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia. Expert Review of Hematology 1:2, pages 217-229.
Read now
Tadeusz Robak. (2008) Alemtuzumab for B-cell chronic lymphocytic leukemia. Expert Review of Anticancer Therapy 8:7, pages 1033-1051.
Read now
Thomas Elter, Istvan Molnar, Jens Kuhlmann, Michael Hallek & Clemens Wendtner. (2008) Pharmacokinetics of alemtuzumab and the relevance in clinical practice. Leukemia & Lymphoma 49:12, pages 2256-2262.
Read now
David Hui, Wendy Lam, Cynthia Toze, Michael Delorme, Michael Noble, Paul Klimo, Judy Sutherland, Karamjit Gill, Joseph Connors & Laurie Sehn. (2008) Alemtuzumab in clinical practice: A British Columbia experience. Leukemia & Lymphoma 49:2, pages 218-226.
Read now
Farhad Ravandi & Susan O'Brien. (2006) Alemtuzumab in CLL and Other Lymphoid Neoplasms. Cancer Investigation 24:7, pages 718-725.
Read now

Articles from other publishers (39)

Lukas K. van Vugt, Marieke van der Zwan, Marian C. Clahsen-van Groningen, Madelon van Agteren, Daphne M. Hullegie-Peelen, Brenda C. M. De Winter, Marlies E. J. Reinders, Pedro Miranda Afonso & Dennis A. Hesselink. (2023) A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection. Transplant International 36.
Crossref
Azam Rahimpour, Es’hagh Pourmaleki, Forough Shams, Zahra Payandeh, Navid Pourzardosht, Mojtaba Didehdar & Milad Gholami. (2022) The effect of Ccnb1ip1 insulator on monoclonal antibody expression in Chinese hamster ovary cells. Molecular Biology Reports 49:5, pages 3461-3468.
Crossref
Jianian Hu, Chongbo Zhao & Jie Lin. (2022) Potential therapeutic strategies in chronic inflammatory demyelinating polyradiculoneuropathy. Autoimmunity Reviews 21:4, pages 103032.
Crossref
Margaret C. Cupit-Link, Amulya Nageswara Rao, Deepti M. Warad, Vilmarie Rodriguez & Shakila Khan. (2018) EBV-PTLD, Adenovirus, and CMV in Pediatric Allogeneic Transplants With Alemtuzumab as Part of Pretransplant Conditioning: A Retrospective Single Center Study. Journal of Pediatric Hematology/Oncology 40:8, pages e473-e478.
Crossref
. Experimental and Clinical Transplantation 16:3.
Crossref
Olivier Hermine, Juan Carlos Ramos & Kensei Tobinai. (2018) A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies. Advances in Therapy 35:2, pages 135-152.
Crossref
Yang Zhao, Huiting Su, Xiaofei Shen, Junfeng Du, Xiaodong Zhang & Yong Zhao. (2017) The immunological function of CD52 and its targeting in organ transplantation. Inflammation Research 66:7, pages 571-578.
Crossref
Mohammad Hojjat-Farsangi. (2015) Novel and emerging targeted-based cancer therapy agents and methods. Tumor Biology 36:2, pages 543-556.
Crossref
Katharina Blatt, Harald Herrmann, Gregor Hoermann, Michael Willmann, Sabine Cerny-Reiterer, Irina Sadovnik, Susanne Herndlhofer, Berthold Streubel, Werner Rabitsch, Wolfgang R. Sperr, Matthias Mayerhofer, Thomas Rülicke & Peter Valent. (2014) Identification of Campath-1 (CD52) as Novel Drug Target in Neoplastic Stem Cells in 5q-Patients with MDS and AML. Clinical Cancer Research 20:13, pages 3589-3602.
Crossref
Darrell J. Irvine, Xingfang Su & Brandon Kwong. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 48 .
Matthieu Broussas, Lucile Broyer & Liliane Goetsch. 2013. Glycosylation Engineering of Biopharmaceuticals. Glycosylation Engineering of Biopharmaceuticals 305 317 .
Hung-Tien Kuo, Edmund Huang, Sina Emami, Phuong-Thu Pham, Alan H. Wilkinson, Gabriel M. Danovitch & Suphamai Bunnapradist. (2012) Effects of Antibody Induction on Transplant Outcomes in Human Leukocyte Antigen Zero-Mismatch Deceased Donor Kidney Recipients. Transplantation 93:5, pages 493-502.
Crossref
Anton B. Alexandroff, Volha Shpadaruk, W. Mark Bamford, D. Ben J. Kennedy, Robert Burd & Martin J. S. Dyer. (2011) Alemtuzumab-resistant Sézary syndrome responding to zanolimumab*. British Journal of Haematology 154:3, pages 419-421.
Crossref
Daniel R GettsSushma Shankar, Emily ML Chastain, Aaron Martin, Meghann Teague Getts, Kathryn Wood & Stephen D Miller. (2011) Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy 3:7, pages 853-870.
Crossref
Nnenna Osuji & Claire Dearden. 2010. Leukemias: Principles and Practice of Therapy. Leukemias: Principles and Practice of Therapy 348 361 .
William Kisaalita. 2010. 3D Cell-Based Biosensors in Drug Discovery Programs. 3D Cell-Based Biosensors in Drug Discovery Programs 289 305 .
Nasia Safdar, Jeannina Smith, Valerie Knasinski, Colleen Sherkow, Casey Herrforth, Stuart Knechtle & David Andes. (2010) Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study. Diagnostic Microbiology and Infectious Disease 66:1, pages 7-15.
Crossref
S Faderl, A Ferrajoli, O Frankfurt & A Pettitt. (2008) Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy. Leukemia 23:3, pages 457-466.
Crossref
Thomas Elter, Janne J. Vehreschild, John Gribben, Oliver A. Cornely, Andreas Engert & Michael Hallek. (2008) Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab. Annals of Hematology 88:2, pages 121-132.
Crossref
Che K Lim, Li Sun, Qi Feng, Ping Law, Wei T Chua, Shy N Lim & William YK Hwang. (2008) Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells. Journal of Hematology & Oncology 1:1.
Crossref
Ajda T. Rowshani, Frederieke J. Bemelman, Neubury M. Lardy & Ineke J.M. Ten Berge. (2008) Humoral immunity in renal transplantation: clinical significance and therapeutic approach. Clinical Transplantation 22:6, pages 689-699.
Crossref
Hanneke C. Kluin-NelemansJules L. Coenen, James E. Boers, Gustaaf W. van ImhoffStefano Rosati. (2008) EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma. Blood 112:4, pages 1039-1041.
Crossref
Xiao-yun Liu, Laurentiu M. Pop & Ellen S. Vitetta. (2008) Engineering therapeutic monoclonal antibodies. Immunological Reviews 222:1, pages 9-27.
Crossref
Susan O'BrienFarhad RavandiTodd Riehl, William WierdaXuelin Huang, Jeffrey Tarrand, Brandi O'NealHagop KantarjianMichael Keating. (2008) Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. Blood 111:4, pages 1816-1819.
Crossref
Claire E. Saadeh & Gordan Srkalovic. (2012) Mycobacterium avium Complex Infection After Alemtuzumab Therapy for Chronic Lymphocytic Leukemia . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:2, pages 281-284.
Crossref
David Gómez-Almaguer, Guillermo J. Ruiz-Argüelles, Luz del Carmen Tarín-Arzaga, Oscar González-Llano, Homero Gutiérrez-Aguirre, Olga Cantú-Rodríguez, José Jaime-Pérez, Antonio Carrasco-Yalán & Sergio Giralt. (2008) Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation 14:1, pages 10-15.
Crossref
Wouter Korver, Shweta Singh, Shouchun Liu, Xiaoxian Zhao, Shirlee Yonkovich, Allison Sweeney, Kristin Anton, Woodrow E. LomasIIIIII, Rachel Greenwood, Ashley Smith, Denise Hoang Tran, Pauline Shinkawa, Mark Jimenez, Patricia Yeung, Gerard Aguilar, Servando Palencia, Paolo Vatta, Matthew Mueller, Xiaoming Zhan, Elizabeth M. Newton, Yi Liu, Jingsong Zhao, Peter Emtage, Michael D. Levy, Eric D. Hsi, Walter D. Funk & Arie Abo. (2007) The lymphoid cell surface receptor NTB‐A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics. British Journal of Haematology 137:4, pages 307-318.
Crossref
John M. Vierling. 2007. Liver Immunology. Liver Immunology 391 407 .
L. Bartalena & M. L. Tanda. (2014) Immunotherapy for Graves’ orbitopathy: Easy enthusiasm, but let’s keep trying. Journal of Endocrinological Investigation 29:11, pages 1012-1016.
Crossref
Sonja Hahtola, Soile Tuomela, Laura Elo, Tiina Häkkinen, Leena Karenko, Boguslaw Nedoszytko, Hannele Heikkilä, Ulpu Saarialho-Kere, Jadwiga Roszkiewicz, Tero Aittokallio, Riitta Lahesmaa & Annamari Ranki. (2006) Th1 Response and Cytotoxicity Genes Are Down-Regulated in Cutaneous T-Cell Lymphoma. Clinical Cancer Research 12:16, pages 4812-4821.
Crossref
Alice Peng, Ashley Vo & Stanley C. Jordan. (2006) Transplantation of the highly human leukocyte antigen–sensitized patient: long-term outcomes and future directions. Transplantation Reviews 20:3, pages 146-156.
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:2, pages 89-96.
Crossref
Stanley C. Jordan & Mark D. Pescovitz. (2006) Presensitization: The Problem and Its Management. Clinical Journal of the American Society of Nephrology 1:3, pages 421-432.
Crossref
Razelle Kurzrock & Farhad Ravandi. (2006) Purine Analogues in Advanced T-Cell Lymphoid Malignancies. Seminars in Hematology 43, pages S27-S34.
Crossref
Stephanie Halene, Arthur Zieske & Nancy Berliner. (2006) Sustained remission from angioimmunoblastic T-cell lymphoma induced by alemtuzumab. Nature Clinical Practice Oncology 3:3, pages 165-168.
Crossref
Andrew Zelenetz. 2006. The Lymphomas. The Lymphomas 249 277 .
Mark D Pescovitz. (2005) Drugs for the hypersensitized patient. Current Opinion in Organ Transplantation 10:4, pages 279-283.
Crossref
Martin S. Zand. (2005) Immunosuppression and Immune Monitoring After Renal Transplantation. Seminars in Dialysis 18:6, pages 511-519.
Crossref
. 2005. Köhler’s Invention. Köhler’s Invention 173 184 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.